J Law Med Ethics. 2021;49(1):10-18. doi: 10.1017/jme.2021.3.
Current debates about the roles of the public and private sectors in pharmaceutical innovation have a long history. The extent to which, and ways in which, the public sector supports drug innovation has implications for assessments of the returns to public research funding, taxpayer rights in drugs, the argument the high prices are needed to support drug innovation, and the desirability of patenting publicly funded research.
当前关于公共部门和私营部门在药品创新中的作用的争论由来已久。公共部门在何种程度上以及以何种方式支持药物创新，这对评估公共研究资金的回报、纳税人对药物的权利、需要高价格来支持药物创新的论点以及对专利公共资助研究的可取性都有影响。
